Quốc gia: Vương quốc Anh
Ngôn ngữ: Tiếng Anh
Nguồn: VMD (Veterinary Medicines Directorate)
Feline leukemia virus
Intervet UK Ltd
QI06AA01
Feline leukemia virus
Expired
Revised: December 2010 AN: 01891/2009 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Quantum Cat FeLV 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: PER ML Inactivated sub-unit antigens (gp 70 and FOCMA) of feline leukaemia virus (FeLV) sub-types A, B and C: _minimum_: 2266 ng of gp70 antigen. ADJUVANTS Alhydrogel 2 % Al 2 0 3 50 μl Quil A 25 μg EXCIPIENTS Thiomersal (Preservative) 0.115 mg (maximum) For a full list of excipients see section 6.1 3. PHARMACEUTICAL FORM Solution for injection. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats from 9 weeks of age. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Active immunization of cats to reduce persistent viraemia and lymphoid tumours caused by FeLV infection, and thereby to reduce other diseases associated with FeLV infection. Onset of immunity occurs by approximately 3 weeks after the last dose of the Basic Vaccination Scheme. The duration of immunity is at least 12 months. 4.3 CONTRA-INDICATIONS Unhealthy animals should not be vaccinated. The use of immunosuppressant drugs or procedures within one month of vaccination is contra-indicated. Page 1 of 4 Revised: December 2010 AN: 01891/2009 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES If an anaphylactic reaction occurs, institute treatment according to the clinical signs using adrenaline or other appropriate medication. Vaccination is of no known clinical value in cats with pre-existing FeLV infection, nor will it change the natural course of the disease. The effect of maternally derived antibodies (MDA) on the response to vaccination is not known, but on the basis of published data and field use it is expected that the levels of MDA that will be present at 9 weeks of age will not interfere with the response to vaccination. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS In case of accidental self-injection, wash the area immedia Đọc toàn bộ tài liệu